Drug Profile
Immunoglobulin G - Intas Pharmaceuticals
Alternative Names: Globucel 5%Latest Information Update: 14 Oct 2021
Price :
$50
*
At a glance
- Originator Intas Pharmaceuticals
- Class Immunoglobulin isotypes
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Immunodeficiency disorders
Most Recent Events
- 31 Dec 2006 Launched for Immunodeficiency disorders in India (IV)